Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
Open accessThe DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Abstract
Neonatal hypoxic ischemic encephalopathy (HIE) is a devastating disease that primarily causes neuronal and white matter injury and is among the leading cause of death among infants. Currently there are no well-established treatments; thus, it is important to understand the pathophysiology of the disease and elucidate complications that are creating a gap between basic science and clinical translation. In the development of neuroprotective strategies and translation of experimental results in HIE, there are many limitations and challenges to master based on an appropriate study design, drug delivery properties, dosage, and use in neonates. We will identify understudied targets after HIE, as well as neuroprotective molecules that bring hope to future treatments such as melatonin, topiramate, xenon, interferon-beta, stem cell transplantation. This review will also discuss some of the most recent trials being conducted in the clinical setting and evaluate what directions are needed in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, L., McBride, D. W., Doycheva, D., Dixon, B. J., Krafft, P. R., Zhang, J. H., & Tang, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.020 · Cited by 109
Self-citationRetractedNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“Although there is evidence that suggests that neurogenesis increases after injuries such as HIE, the endogenous repair mechanisms do not resolve the brain damage that occurs [48–50].”
BackgroundThe blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261 · cited 4×
“It is believed that all the components that comprise the BBB are important for stability and proper functioning [33].”
BackgroundInfluentialDimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Dhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,525 · cited 2×
“(JNKs) JNKs play a role in regulation of apoptosis [97]; Reductions in early neuronal damage [98];”
Background1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
Can Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Historical landmarks of autophagy research
Ohsumi, Y. (2014) · Cell Research · doi:10.1038/cr.2013.169 · Cited by 1,089 · cited 2×
“to elucidate exact mechanisms remain, especially following neurodegenerative insults and diseases [54].”
BackgroundDenhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059 · cited 1×
“OPN has both pro- and anti- inflammatory properties; thus, its exact role in injury is not well predicted [95,134,135].”
BackgroundDigicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923 · cited 1×
“STAT5 acts on cell survival [161], while the ERK pathway has demonstrated not only to have anti-apoptotic and anti-inflammatory effects in vitro but also to be essential for neurogenesis and cell fate commitment [162,163].”
BackgroundComparison of Treatment Effects between Animal Experiments and Clinical Trials: Systematic Review
Perel, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C., Sandercock, P., Macleod, M., Mignini, L. E., Jayaram, P., & Khan, K. S. (2007) · BMJ · doi:10.1136/bmj.39048.407928.be · Cited by 827 · cited 1×
“The underlying reason may be drug delivery issues, toxicity, or other problems [60] Even though several reviews demonstrated poorly predictive value of animal models on human outcomes, those experiments are mandatory especially in drug development before translation to clinical trials [61–63].”
BackgroundRoy, N. S., Cleren, C., Singh, S. K., Yang, L., Beal, M. F., & Goldman, S. A. (2006) · Nature Medicine · doi:10.1038/nm1495 · Cited by 821 · cited 2×
“Additionally, cord blood (CB) represents a rich source of stem cells used in several animal models of neurological diseases [129–132,185].”
BackgroundShank, R. P., Gardocki, J. F., Streeter, A. J., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02163.x · Cited by 810 · cited 1×
“Topiramate (TPM) is an anticonvulsant agent with multiple mechanisms of action [174,175], implying its ability to be a neuroprotective agent.”
BackgroundHypoxic-Ischemic Encephalopathy: A Review for the Clinician
Douglas-Escobar, M., & Weiss, M. D. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.3269 · Cited by 778 · cited 7×
“Before the advent of hypothermia, clinicians were not able to provide much care to neonates suffering from HIE besides systemic supportive care [10].”
BackgroundInfluentialWang, L., Zhang, Z., Wang, Y., Zhang, R., & Chopp, M. (2004) · Stroke · doi:10.1161/01.str.0000132196.49028.a4 · Cited by 763 · cited 1×
“Vasogenic and pro-angiogenic functions [109];”
Wasterlain, C. G. (1990) · Cited by 741
Translation of Research Evidence From Animals to Humans
Hackam, D. G., & Redelmeier, D. A. (2006) · JAMA · doi:10.1001/jama.296.14.1731 · Cited by 733 · cited 1×
“The underlying reason may be drug delivery issues, toxicity, or other problems [60] Even though several reviews demonstrated poorly predictive value of animal models on human outcomes, those experiments are mandatory especially in drug development before translation to clinical trials [61–63].”
BackgroundA Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715 · cited 1×
“Hypoxia-inducible-factor-1 mediates increase in EPO expression [111,112]”
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042604 · Cited by 709 · cited 1×
“Studies analyzing the risk and benefits of autologous CB infusion in neonates with HIE and in children with cerebral palsy show promising results [133,186,187].”
BackgroundPublication bias in reports of animal stroke studies leads to major overstatement of efficacy
Sena, E. S., van der Worp, H. B., Bath, P. M. W., Howells, D. W., & Macleod, M. R. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000344 · Cited by 600 · cited 1×
“Although much progress in experimental development and technology has been made in the past few decades, the issue of discovering disease models, that can mimic human pathophysiology sufficiently, remains an ongoing challenge [73,77,78].”
BackgroundLorek, A., Takei, Y., Cady, E. B., Wyatt, J. S., Penrice, J., Edwards, A. D., Peebles, D., Wylezinska, M., Owen-Reece, H., Kirkbride, V, et al. (1994) · Pediatric Research · doi:10.1203/00006450-199412000-00003 · Cited by 561 · cited 2×
“neurotransmitters and free radicals as well as depletion of high phosphate reserves, but differs from the primary energy failure phase since it is independent of cerebral acidosis [30,31].”
BackgroundPark, K. I., Teng, Y. D., & Snyder, E. Y. (2002) · Nature Biotechnology · doi:10.1038/nbt751 · Cited by 554
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 528 · cited 1×
“Treatment strategies for central nervous system (CNS) diseases are challenged by the drug delivery mechanisms for crossing the BBB [79].”
BackgroundVilla, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T. R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021067 · Cited by 527 · cited 2×
“properties [108–110];”
BackgroundAlavijeh, M. S., Chishty, M., Qaiser, M. Z., & Palmer, A. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.554 · Cited by 497 · cited 1×
“The underlying reason, also considered the bottleneck in CNS drug development, is in most cases since insufficient attention to the prediction and assessment of the compounds ability to cross the BBB [80].”
BackgroundHypoxia–ischemia in the immature brain
Vannucci, S. J., & Hagberg, H. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01064 · Cited by 446 · cited 1×
“Also, a thorough evaluation method of the developmental and behavioral sequelae after brain injury needs to be established [58].”
MethodPerinatal brain injury: From pathogenesis to neuroprotection
Volpe, J. J. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/1098-2779(200102)7:1<56::aid-mrdd1008>3.0.co;2-a · Cited by 438 · cited 1×
“HIE has tremendous detrimental effects on the developing brain and is among the leading causes of death among infants, as well as the major underlying cause of seizures in term infants [1–3].”
BackgroundFrom JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical Importance
Karin, M., & Gallagher, E. (2005) · IUBMB Life · doi:10.1080/15216540500097111 · Cited by 412 · cited 1×
“c-Jun N-terminal kinases (JNKs) activation is associated with an assortment of environmental stressors and for that reason they are known as stress activated protein kinases [141,142].”
BackgroundJohnston, M. V., Trescher, W. H., Ishida, A., Nakajima, W., & Zipursky, A. (2001) · Pediatric Research · doi:10.1203/00006450-200106000-00003 · Cited by 407 · cited 2×
“nitric oxide synthase giving rise to free radical production and mitochondrial dysfunction [26].”
BackgroundOsteopontin—a molecule for all seasons
Mazzali, M., Kipari, T., Ophascharoensuk, V., Wesson, J. A., Johnson, R., & Hughes, J. (2002) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/95.1.3 · Cited by 392 · cited 1×
“OPN has both pro- and anti- inflammatory properties; thus, its exact role in injury is not well predicted [95,134,135].”
BackgroundNeonatal encephalopathy: An inadequate term for hypoxic–ischemic encephalopathy
Volpe, J. J. (2012) · Annals of Neurology · doi:10.1002/ana.23647 · Cited by 390 · cited 1×
“It is also critically important to eliminate other causes of neonatal encephalopathy in order to prevent delay in diagnosis and neuroprotective intervention [17].”
BackgroundNeuronal cell death in neonatal hypoxia‐ischemia
Northington, F. J., Chavez‐Valdez, R., & Martin, L. J. (2011) · Annals of Neurology · doi:10.1002/ana.22419 · Cited by 380 · cited 3×
“There are some experiments that describe pharmacological inhibition of autophagy being neuroprotective, while others have shown that inducing autophagy immediately after injury may be an endogenous neuroprotective mechanism [4].”
BackgroundInfluentialCell transplantation therapy for stroke
Bliss, T., Guzman, R., Daadi, M., & Steinberg, G. K. (2007) · Stroke · doi:10.1161/01.str.0000247888.25985.62 · Cited by 374 · cited 1×
“increase neurogenesis and an angiogenesis [132,133]”
Magnesium Decreases Inflammatory Cytokine Production: A Novel Innate Immunomodulatory Mechanism
Sugimoto, J., Romani, A. M., Valentin-Torres, A. M., Luciano, A. A., Ramirez Kitchen, C. M., Funderburg, N., Mesiano, S., & Bernstein, H. B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101765 · Cited by 368
How can we improve the pre-clinical development of drugs for stroke?
Sena, E., van der Worp, H. B., Howells, D., & Macleod, M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.009 · Cited by 365 · cited 1×
“Although, biologically proximity to humans seems to be important in animal studies, over 95% of experiments in general were performed in rats and mice [72,73].”
BackgroundOsteopontin: a key cytokine in cell‐mediated and granulomatous inflammation
O'Regan, A., & Berman, J. S. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00163.x · Cited by 357 · cited 2×
“proliferation, cell survival, and oligodendrocyte differentiation after injury [95]”
BackgroundErythropoietin Improved Neurologic Outcomes in Newborns With Hypoxic-Ischemic Encephalopathy
Zhu, C., Kang, W., Xu, F., Cheng, X., Zhang, Z., Jia, L., Ji, L., Guo, X., Xiong, H., Simbruner, G., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-3553 · Cited by 354 · cited 3×
“the CSF [149,150,152,153].”
BackgroundFeasibility of Autologous Cord Blood Cells for Infants with Hypoxic-Ischemic Encephalopathy
Cotten, C. M., Murtha, A. P., Goldberg, R. N., Grotegut, C. A., Smith, P. B., Goldstein, R. F., Fisher, K. A., Gustafson, K. E., Waters-Pick, B., Swamy, G. K., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.11.036 · Cited by 334 · cited 2×
“of autologous CB infusion in term infants with HIE (NCT00593242) [133,188].”
BackgroundTopiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes
Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb06047.x · Cited by 316
Follett, P. L., Deng, W., Dai, W., Talos, D. M., Massillon, L. J., Rosenberg, P. A., Volpe, J. J., & Jensen, F. E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0477-04.2004 · Cited by 314 · cited 2×
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundHypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments
Allen, K. A., & Brandon, D. H. (2011) · Newborn and Infant Nursing Reviews · doi:10.1053/j.nainr.2011.07.004 · Cited by 295 · cited 1×
“Since the pathophysiology of HIE injury is quite complex, there are a myriad of potential interventional targets following HIE where prevention of cellular damage can occur [22] (Figure 1).”
BackgroundTreatment advances in neonatal neuroprotection and neurointensive care
Johnston, M. V., Fatemi, A., Wilson, M. A., & Northington, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70016-3 · Cited by 278 · cited 1×
“Although there has been much progress, further investigation is needed to discover adjuvant neuroprotective strategies [94].”
BackgroundXenon and hypothermia combine to provide neuroprotection from neonatal asphyxia
Ma, D., Hossain, M., Chow, A., Arshad, M., Battson, R. M., Sanders, R. D., Mehmet, H., Edwards, A. D., Franks, N. P., & Maze, M. (2005) · Annals of Neurology · doi:10.1002/ana.20547 · Cited by 276 · cited 2×
“combination with hypothermia (neonatal rodents) [116]”
BackgroundThe neuroprotective roles of BDNF in hypoxic ischemic brain injury
CHEN, A., XIONG, L.-J., TONG, Y., & MAO, M. (2013) · Biomedical Reports · doi:10.3892/br.2012.48 · Cited by 267 · cited 1×
“Neurogenesis is comprised of cell proliferation, migration and differentiation [47].”
BackgroundTargeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., & Barr, R. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.016 · Cited by 266 · cited 1×
“c-Jun N-terminal kinases (JNKs) activation is associated with an assortment of environmental stressors and for that reason they are known as stress activated protein kinases [141,142].”
BackgroundMelatonin augments hypothermic neuroprotection in a perinatal asphyxia model
Robertson, N. J., Faulkner, S., Fleiss, B., Bainbridge, A., Andorka, C., Price, D., Powell, E., Lecky-Thompson, L., Thei, L., Chandrasekaran, M., et al. (2013) · Brain · doi:10.1093/brain/aws285 · Cited by 254
van Velthoven, C. T. J., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.017 · Cited by 252
Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study
Aly, H., Elmahdy, H., El-Dib, M., Rowisha, M., Awny, M., El-Gohary, T., Elbatch, M., Hamisa, M., & El-Mashad, A.-R. (2015) · Journal of Perinatology · doi:10.1038/jp.2014.186 · Cited by 245 · cited 3×
“Intravenous use of melatonin showed efficacy and feasibility when used in neonates with HIE who were receiving whole body therapeutic hypothermia [104].”
BackgroundInfluentialInfarct Volume as a Surrogate or Auxiliary Outcome Measure in Ischemic Stroke Clinical Trials
Saver, J. L., Johnston, K. C., Homer, D., Wityk, R., Koroshetz, W., Truskowski, L. L., & Haley, E. C. (1999) · Stroke · doi:10.1161/01.str.30.2.293 · Cited by 244 · cited 1×
“Other points to consider are the inevitable delays between symptom onset and start of treatment [74,75] or”
BackgroundHobbs, C., Thoresen, M., Tucker, A., Aquilina, K., Chakkarapani, E., & Dingley, J. (2008) · Stroke · doi:10.1161/strokeaha.107.499822 · Cited by 242 · cited 1×
“Similarly, other studies have also proven this combination to be beneficial [169,170].”
ResultEpidemiology and aetiology of neonatal seizures
Vasudevan, C., & Levene, M. (2013) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2013.05.008 · Cited by 239 · cited 1×
“Since HIE is the major underlying cause of seizures in term infants, a large variety of seizures may present [12].”
BackgroundMeier, C., Middelanis, J., Wasielewski, B., Neuhoff, S., Roth-Haerer, A., Gantert, M., Dinse, H. R., Dermietzel, R., & Jensen, A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000197309.08852.f5 · Cited by 235
Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Sanchez-Covarrubias, L., Slosky, L., Thompson, B., Davis, T., & Ronaldson, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990463 · Cited by 231 · cited 1×
“This demands research focusing on signaling pathways and trafficking mechanisms, as involved brain transporters at the BBB and brain-cerebrospinal fluid-barrier [82].”
BackgroundSilverstein, F. S., & Jensen, F. E. (2007) · Annals of Neurology · doi:10.1002/ana.21167 · Cited by 218
Perinatal Hypoxic‐Ischemic Encephalopathy
Lai, M.-C., & Yang, S.-N. (2011) · BioMed Research International · doi:10.1155/2011/609813 · Cited by 209 · cited 2×
“This reliance upon anaerobic metabolism pathways leads to the collection of lactic acid and depletion of adenosine triphosphate (ATP) [27].”
BackgroundErythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics
Wu, Y. W., Bauer, L. A., Ballard, R. A., Ferriero, D. M., Glidden, D. V., Mayock, D. E., Chang, T., Durand, D. J., Song, D., Bonifacio, S. L., et al. (2012) · Pediatrics · doi:10.1542/peds.2012-0498 · Cited by 208
Are In Vitro Tests Suitable for Regulatory Use?
Hartung, T., & Daston, G. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp149 · Cited by 202
Daadi, M. M., Davis, A. S., Arac, A., Li, Z., Maag, A.-L., Bhatnagar, R., Jiang, K., Sun, G., Wu, J. C., & Steinberg, G. K. (2010) · Stroke · doi:10.1161/strokeaha.109.573691 · Cited by 201
Immunohistochemical Localization of Erythropoietin and Its Receptor in the Developing Human Brain
Juul, S. E., Yachnis, A. T., Rojiani, A. M., & Christensen, R. D. (1999) · Pediatric and Developmental Pathology · doi:10.1007/s100249900103 · Cited by 198 · cited 1×
“Epo levels are increased in newborn infants with HIE in the cerebrospinal fluid despite the absence of exogenous Epo treatment [148].”
BackgroundHuman Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial
Elmahdy, H., El-Mashad, A.-R., El-Bahrawy, H., El-Gohary, T., El-Barbary, A., & Aly, H. (2010) · Pediatrics · doi:10.1542/peds.2009-2268 · Cited by 198
Kumral, A., Uysal, N., Tugyan, K., Sonmez, A., Yilmaz, O., Gokmen, N., Kiray, M., Genc, S., Duman, N., Koroglu, T. F., et al. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.002 · Cited by 191 · cited 1×
“In addition, a treatment group that received Epo but did not undergo HIE, showed no differential effects concerning learning or memory from the treatment [155].”
Backgroundvan Velthoven, C. T. J., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1835-10.2010 · Cited by 182
Blood-brain barrier dysfunction in disorders of the developing brain
Moretti, R., Pansiot, J., Bettati, D., Strazielle, N., Ghersi‐Egea, J., Damante, G., Fleiss, B., Titomanlio, L., & Gressèns, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00040 · Cited by 178
Pimentel‐Coelho, P. M., Magalhães, E. S. D. S., Lopes, L. M., deAzevedo, L. C., Santiago, M. F., & Méndez‐Otero, R. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0049 · Cited by 178
Donega, V., Nijboer, C. H., van Tilborg, G., Dijkhuizen, R. M., Kavelaars, A., & Heijnen, C. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.009 · Cited by 175
Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage
van Velthoven, C. T. J., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181f1c289 · Cited by 174
Allopurinol Administered after Inducing Hypoxia-Ischemia Reduces Brain Injury in 7-Day-Old Rats
Palmer, C., Towfighi, J., Roberts, R. L., & Heitjan, D. F. (1993) · Pediatric Research · doi:10.1203/00006450-199304000-00018 · Cited by 174 · cited 2×
“Allopurinol Neuroprotection in postnatal day 7 rats after HI [113];”
BackgroundCHEN, A., XIONG, L.-J., TONG, Y., & MAO, M. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1628 · Cited by 174 · cited 1×
“ultimately induced autophagy and exerted protective effects [57].”
BackgroundGinet, V., Puyal, J., Clarke, P. G. H., & Truttmann, A. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090463 · Cited by 171 · cited 2×
“importance that have been understudied [24,25].”
BackgroundPark, K. I., Himes, B. T., Stieg, P. E., Tessler, A., Fischer, I., & Snyder, E. Y. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.016 · Cited by 170
General anesthetics and the developing brain
Istaphanous, G. K., & Loepke, A. W. (2009) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283294c9e · Cited by 169 · cited 1×
“However, a recent review by Istaphanous and Loepke demonstrated that xenon may trigger neurodegeneration in the developing brain [168].”
BackgroundPharmacologic Neuroprotective Strategies in Neonatal Brain Injury
Juul, S. E., & Ferriero, D. M. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2013.09.004 · Cited by 165 · cited 3×
“development changes that occurs in neonates over time [29].”
BackgroundInfluentialThoresen, M., Hobbs, C. E., Wood, T., Chakkarapani, E., & Dingley, J. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.163 · Cited by 164 · cited 1×
“Similarly, other studies have also proven this combination to be beneficial [169,170].”
ResultCarloni, S., Perrone, S., Buonocore, G., Longini, M., Proietti, F., & Balduini, W. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00503.x · Cited by 161 · cited 2×
“Melatonin Antioxidant, anti-inflammatory, and anti-apoptotic properties [101,102];”
BackgroundHypoxic-Ischemic Encephalopathy in Preterm Infants: Antecedent Factors, Brain Imaging, and Outcome
Logitharajah, P., Rutherford, M. A., & Cowan, F. M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181a9ef34 · Cited by 160 · cited 2×
“Neonatal hypoxic ischemic encephalopathy is of great importance since it is the major cause and contributor to global infant mortality and morbidity [11].”
BackgroundWhich Neuroprotective Agents are Ready for Bench to Bedside Translation in the Newborn Infant?
Robertson, N. J., Tan, S., Groenendaal, F., van Bel, F., Juul, S. E., Bennet, L., Derrick, M., Back, S. A., Chavez Valdez, R., Northington, F., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.052 · Cited by 159
Human Dental Pulp-Derived Stem Cells Protect Against Hypoxic-Ischemic Brain Injury in Neonatal Mice
Yamagata, M., Yamamoto, A., Kako, E., Kaneko, N., Matsubara, K., Sakai, K., Sawamoto, K., & Ueda, M. (2012) · Stroke · doi:10.1161/strokeaha.112.676759 · Cited by 155
Pharmacokinetics of High-Dose Recombinant Erythropoietin in Plasma and Brain of Neonatal Rats
Statler, P., McPherson, R. J., Bauer, L. A., Kellert, B., & Juul, S. E. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31805341dc · Cited by 155 · cited 1×
“the CSF [149,150,152,153].”
Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes
Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02169.x · Cited by 150 · cited 1×
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundMechanisms of Perinatal Arterial Ischemic Stroke
Fernández‐López, D., Natarajan, N., Ashwal, S., & Vexler, Z. S. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.41 · Cited by 149 · cited 1×
“Discovering and understanding the factors that promote neurogenesis during normal physiological conditions as well as the impairment that occurs during brain damage are key questions that need to be determined [50,53].”
BackgroundAnimal Models of Perinatal Hypoxic-Ischemic Brain Damage
Yager, J. Y., & Ashwal, S. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.10.025 · Cited by 148 · cited 1×
“Thus, it is critical to have an appropriate treatment to provide protection to neonates suffering from HIE [21].”
BackgroundRodríguez‐Gómez, J. A., Lu, J., Velasco, I., Rivera, S. N., Zoghbi, S. S., Liow, J., Musachio, J. L., Chin, F. T., Toyama, H., Seidel, J., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0386 · Cited by 148 · cited 1×
“Several sources for stem cells include neural stem/progenitor cells derived from fetal tissue, mesenchymal stem cells or embryonic stem-induced pluripotent stem cells [129,130] (Figure 3).”
BackgroundFree Radical Injury and Blood-Brain Barrier Permeability in Hypoxic-Ischemic Encephalopathy
Kumar, A., Mittal, R., Khanna, H. D., & Basu, S. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0269 · Cited by 148 · cited 2×
“In an observational study of term neonates with HIE, it was found that BBB permeability is a contributing factor to HIE [34].”
BackgroundOng, J. E., Plane, J. M., Parent, J. M., & Silverstein, F. S. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000179381.86809.02 · Cited by 147 · cited 2×
“These results also suggest depletion of the neuronal progenitor pool since they are more vulnerable to HIE than SVZ stem cells or that the environment is not conducive to the maturation and survival of newly formed neurons since there maybe a lack of trophic support [51].”
BackgroundKoh, S., Tibayan, F. D., Simpson, J. N., & Jensen, F. E. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.69103.x · Cited by 147 · cited 2×
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundRecent highlights in the development of new antiviral drugs
Clercq, E. D. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.010 · Cited by 145 · cited 1×
“The underlying reason may be drug delivery issues, toxicity, or other problems [60] Even though several reviews demonstrated poorly predictive value of animal models on human outcomes, those experiments are mandatory especially in drug development before translation to clinical trials [61–63].”
BackgroundYasuhara, T., Hara, K., Maki, M., Xu, L., Yu, G., Ali, M. M., Masuda, T., Yu, S. J., Bae, E. K., Hayashi, T., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00671.x · Cited by 144
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist
Kaminski, R. M., Banerjee, M., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.010 · Cited by 142 · cited 2×
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundChabot, S., Williams, G., & Yong, V. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119571 · Cited by 141 · cited 1×
“and pro-inflammatory cytokines produced by T-cells; Blood Brain Barrier integrity [96]”
BackgroundEk, C. J., D’Angelo, B., Baburamani, A. A., Lehner, C., Leverin, A., Smith, P. L. P., Nilsson, H., Svedin, P., Hagberg, H., & Mallard, C. E. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.255 · Cited by 141 · cited 1×
“More understanding of this phenomenon might provide an opportunity window for compounds to access the brain tissue easier after HIE [83].”
BackgroundLee, S., Chu, K., Sinn, D., Jung, K., Kim, E., Kim, S., Kim, J., Ko, S., Kim, M., & Roh, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03697.x · Cited by 139 · cited 1×
“STAT5 acts on cell survival [161], while the ERK pathway has demonstrated not only to have anti-apoptotic and anti-inflammatory effects in vitro but also to be essential for neurogenesis and cell fate commitment [162,163].”
BackgroundZeevalk, G. D., & Nicklas, W. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08430.x · Cited by 138
Lithium reduces apoptosis and autophagy after neonatal hypoxia–ischemia
Li, Q., Li, H., Roughton, K., Wang, X., Kroemer, G., Blomgren, K., & Zhu, C. (2010) · Cell Death & Disease · doi:10.1038/cddis.2010.33 · Cited by 137 · cited 1×
“Autophagy is a lysosomal pathway for intracellular degradation of macromolecules and organelles that plays an important part to maintaining cellular survival and homeostasis [55].”
BackgroundJuul, S. E., McPherson, R. J., Farrell, F. X., Jolliffe, L. K., Ness, D. J., & Gleason, C. A. (2003) · Neonatology · doi:10.1159/000074970 · Cited by 137 · cited 2×
“the CSF [149,150,152,153].”
BackgroundSecondary Energy Failure after Cerebral Hypoxia–Ischemia in the Immature Rat
Vannucci, R. C., Towfighi, J., & Vannucci, S. J. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000133250.03953.63 · Cited by 137 · cited 1×
“neurotransmitters and free radicals as well as depletion of high phosphate reserves, but differs from the primary energy failure phase since it is independent of cerebral acidosis [30,31].”
BackgroundBaburamani, A. A., Ek, C. J., Walker, D. W., & Castillo-Melendez, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00424 · Cited by 135
The long‐term health, social, and financial burden of hypoxic–ischaemic encephalopathy
Eunson, P. (2015) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12727 · Cited by 133 · cited 1×
“Thus, neonatal HIE is described as acute intrapartum events that cause moderate to severe neonatal encephalopathy, metabolic acidosis in fetal umbilical arterial blood obtained at delivery, spastic or dyskinetic quadraparesis, and absence of other causes of cerebral palsy [16].”
BackgroundThe Mechanism of Neuroprotection by Topiramate in an Animal Model of Epilepsy
Kudin, A. P., Debska‐Vielhaber, G., Vielhaber, S., Elger, C. E., & Kunz, W. S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.13504.x · Cited by 132 · cited 1×
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundErythropoietin Sustains Cognitive Function and Brain Volume after Neonatal Stroke
Gonzalez, F. F., Abel, R., Almli, C. R., Mu, D., Wendland, M. F., & Ferriero, D. M. (2009) · Developmental Neuroscience · doi:10.1159/000232558 · Cited by 132 · cited 1×
“each) caused increases in hemispheric volume and its sub regions, as well as spatial learning and memory [156].”
BackgroundSynergistic neuroprotective therapies with hypothermia
Cilio, M. R., & Ferriero, D. M. (2010) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2010.02.002 · Cited by 127 · cited 1×
“Hypothermia plus adjuvant therapies have been extensively reviewed in two recent publications [172,173].”
BackgroundMesenchymal Stem-Cell Transplantation for Hypoxic-Ischemic Brain Injury in Neonatal Rat Model
Lee, J. A., Kim, B. I., Jo, C. H., Choi, C. W., Kim, E., Kim, H., Yoon, K.-S., & Choi, J.-H. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181bf594b · Cited by 127
Veldhuis, W. B., Floris, S., van der Meide, P. H., Vos, I. M. P., de Vries, H. E., Dijkstra, C. D., Bär, P. R., & Nicolay, K. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000080701.47016.24 · Cited by 126 · cited 1×
“Intrastriatal injections IFNβ has been shown to preserve the BBB integrity, decrease infarct size, and block the infiltration of inflammatory cells in a middle cerebral artery occlusion model [139].”
BackgroundPark, W. S., Sung, S. I., Ahn, S. Y., Yoo, H. S., Sung, D. K., Im, G. H., Choi, S. J., & Chang, Y. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120893 · Cited by 126
Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
Douglas-Escobar, M., & Weiss, M. D. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00144 · Cited by 125 · cited 1×
“that can be used along with the brain imaging, and long-term neuro-assessments [193,194].”
MethodMethodological quality of animal studies on neuroprotection in focal cerebral ischaemia
van der Worp, H. B., de Haan, P. S., Morrema, E., & Kalkman, C. J. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0802-3 · Cited by 120
Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia
Alconada, D. A., Alvarez, A. A., Arteaga, O., Martínez-Ibargüen, A., & Hilario, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059379 · Cited by 119 · cited 1×
“Melatonin Antioxidant, anti-inflammatory, and anti-apoptotic properties [101,102];”
Hoffman, D. J., Marro, P. J., McGowan, J. E., Mishra, O. P., & Delivoria‐Papadopoulos, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90357-3 · Cited by 119 · cited 1×
“Evidence leads researchers to believe that it also reduces secondary inflammation and associated injury [179], acts on cell membrane stabilization and inhibition of free radical production [180], and improves cardiovascular stability [181].”
BackgroundFollow-up of the term infant after hypoxic-ischemic encephalopathy
Robertson, C. M. T., & Perlman, M. (2006) · Paediatrics & Child Health · doi:10.1093/pch/11.5.278 · Cited by 118 · cited 1×
“This system consists of three stages ranging from mild, moderate, and severe, all based on clinical symptoms described above, along with electroencephalogram evaluation [18].”
Mu, D., Chang, Y. S., Vexler, Z. S., & Ferriero, D. M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.001 · Cited by 117 · cited 2×
“microglia [111,112].”
Potential biomarkers for hypoxic–ischemic encephalopathy
Bennet, L., Booth, L. C., & Gunn, A. J. (2010) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2010.05.007 · Cited by 117 · cited 1×
“that can be used along with the brain imaging, and long-term neuro-assessments [193,194].”
MethodEarly postnatal allopurinol does not improve short term outcome after severe birth asphyxia: Table 1
Benders, M. J. N. L., Bos, A. F., Rademaker, C. M. A., Rijken, M., Torrance, H. L., Groenendaal, F., & van Bel, F. (2006) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.086652 · Cited by 115 · cited 1×
“Even though Benders and colleagues did not show improvement in outcomes with after-birth asphyxia [165], a recent follow-up study in human neonates with allopurinol used on term asphyxiated neonates showed benefits on mortality and severe disabilities at 4–8 years of age [166].”
ResultXenocostas, A., Cheung, W. K., Farrell, F. X., Zakszewski, C., Kelley, M. M., Lutynski, A., Crump, M., Lipton, J. H., Kiss, T. L., Lau, C. Y., et al. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0896-7 · Cited by 114 · cited 1×
“the CSF [149,150,152,153].”
Peeters‐Scholte, C. M. P. C. D., Braun, K. P. J., Koster, J. G., Kops, N., Blomgren, K., Buonocore, G., van Buul-Offers, S. C., Hagberg, H., Nicolay, K., van Bel, F., et al. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000081297.53793.c6 · Cited by 112 · cited 1×
“In addition, allopurinol functions as a chelator of non-protein bound iron as well as a direct scavenger of hydroxyl radicals, suggesting it may serve in neuroprotection [164].”
BackgroundXenon Ventilation During Therapeutic Hypothermia in Neonatal Encephalopathy: A Feasibility Study
Dingley, J., Tooley, J., Liu, X., Scull-Brown, E., Elstad, M., Chakkarapani, E., Sabir, H., & Thoresen, M. (2014) · Pediatrics · doi:10.1542/peds.2013-0787 · Cited by 111 · cited 1×
“Xenon was reported to be safe for use in a phase II randomized study outcomes after demonstrating to have similar results as cooling therapy alone [171].”
ResultBrief Update on Animal Models of Hypoxic-Ischemic Encephalopathy and Neonatal Stroke
Northington, F. J. (2006) · ILAR Journal · doi:10.1093/ilar.47.1.32 · Cited by 109 · cited 1×
“The great variety of established models and promising new designs points out the importance of carefully choosing the appropriate model, especially for testing possible treatment strategies [69].”
BackgroundSchira‐Heinen, J., Gasis, M., Estrada, V., Hendricks, M., Schmitz, C., Trapp, T., Kruse, F., Kögler, G., Wernet, P., Hartung, H., et al. (2011) · Brain · doi:10.1093/brain/awr222 · Cited by 109 · cited 1×
“Additionally, cord blood (CB) represents a rich source of stem cells used in several animal models of neurological diseases [129–132,185].”
BackgroundPharmacokinetics of melatonin in preterm infants
Merchant, N. M., Azzopardi, D., Hawwa, A. F., McElnay, J. C., Middleton, B., Arendt, J., Arichi, T., Gressèns, P., & Edwards, A. D. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12092 · Cited by 107 · cited 1×
“With its effectiveness for both pre-term and term infants [145] it holds considerable promise as an adjunct therapy [146] and results from various studies suggest combination therapy as the most effective.”
ResultHuman Umbilical Cord Blood Cells Restore Brain Damage Induced Changes in Rat Somatosensory Cortex
Geißler, M., Dinse, H. R., Neuhoff, S., Kreikemeier, K., & Meier, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020194 · Cited by 105
Costa, C., Martella, G., Picconi, B., Prosperetti, C., Pisani, A., Filippo, M. D., Pisani, F., Bernardi, G., & Calabresi, P. (2006) · Stroke · doi:10.1161/01.str.0000217303.22856.38 · Cited by 103 · cited 1×
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundDavid, H., Haelewyn, B., Rouillon, C., Lecoq, M., Chazalviel, L., Apiou, G., Risso, J., Lemaire, M., & Abraini, J. H. (2007) · The FASEB Journal · doi:10.1096/fj.07-9420com · Cited by 103
Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats
Noh, M. R., KIM, S., Sun, W., Park, S. J., Choi, H. S., Lim, J. H., Kim, I., Kim, H. J., Kim, H. J., & Eun, B. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.038 · Cited by 101 · cited 2×
“In addition, Noh and colleagues [125] reported that i.”
BackgroundEngelhardt, S., Huang, S., Patkar, S., Gassmann, M., & Ogunshola, O. O. (2015) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-12-4 · Cited by 100
Autophagy in hypoxia-ischemia induced brain injury
Balduini, W., Carloni, S., & Buonocore, G. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.663176 · Cited by 98 · cited 1×
“Since autophagy is a tightly regulated process, controversy of whether or not autophagy provides beneficial effects after HIE currently exists [56].”
BackgroundHypoxia Dramatically Increases the Nonspecific Transport of Blood‐Borne Proteins to the Brain
Plateel, M., Teissier, E., & Cecchelli, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020874.x · Cited by 94 · cited 1×
“In the setting of HIE there is an increase in permeability of the blood brain barrier [149–151], allowing high doses of Epo to increase its levels in”
Backgroundde Haan, H. H., Gunn, A. J., Williams, C. E., Heymann, M. A., & Gluckman, P. D. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)80005-1 · Cited by 94
Ängehagen, M., Rönnbäck, L., Hansson, E., & Ben‐Menachem, E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03259.x · Cited by 93
Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy
Rogers, E. E., Bonifacio, S. L., Glass, H. C., Juul, S. E., Chang, T., Mayock, D. E., Durand, D. J., Song, D., Barkovich, A. J., Ballard, R. A., et al. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.08.010 · Cited by 93 · cited 1×
“There have been several completed clinical trials concerning Epo after HIE injury [150,157–159].”
BackgroundNijboer, C. H. A., van der Kooij, M. A., van Bel, F., Ohl, F., Heijnen, C. J., & Kavelaars, A. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.09.008 · Cited by 92 · cited 2×
“The present study shows that early JNK inhibition by the short-lived TAT-JBD peptide may be a promising therapy for neonatal HIE by conferring long-term anatomical and behavioral improvements [143].”
BackgroundTopiramate prevents excitotoxic damage in the newborn rodent brain
Sfaello, I., Baud, O., Arzimanoglou, A. A., & Gressèns, P. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.019 · Cited by 88 · cited 1×
“Similarly, it leads to dose dependent and long lasting neuroprotection in the excitotoxic newborn mouse model [177].”
BackgroundHypoxic-ischemic Encephalopathy and Novel Strategies for Neuroprotection
Shankaran, S. (2012) · Clinics in Perinatology · doi:10.1016/j.clp.2012.09.008 · Cited by 88 · cited 1×
“Although there have been major advances in modern technology and an increased understanding of fetal and neonatal pathologies, HIE is still a serious condition that is unresolved and causes significant mortality and long-term morbidity [4–7].”
BackgroundNeonatal seizures in hypoxic–ischaemic encephalopathy – risks and benefits of anticonvulsant therapy
Shetty, J. (2015) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12724 · Cited by 88 · cited 1×
“HIE has tremendous detrimental effects on the developing brain and is among the leading causes of death among infants, as well as the major underlying cause of seizures in term infants [1–3].”
Backgroundde Paula, S., Vitola, A. S., Greggio, S., de Paula, D., Mello, P. B., Lubianca, J. M., Xavier, L. L., Fiori, H. H., & DaCosta, J. C. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819ed5c8 · Cited by 87
Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic–ischemic encephalopathy
Pimentel‐Coelho, P. M., Rosado-de-Castro, P. H., da Fonseca, L. M. B., & Méndez‐Otero, R. (2012) · Pediatric Research · doi:10.1038/pr.2011.59 · Cited by 85 · cited 1×
“by the transplantation of CD34+ cells from umbilical cord blood and that this improvement is beneficial [46].”
BackgroundKaandorp, J. J., van Bel, F., Veen, S., Derks, J. B., Groenendaal, F., Rijken, M., Roze, E., Venema, M. M. U., Rademaker, C. M., Bos, A. F., et al. (2012) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/archdischild-2011-300356 · Cited by 84 · cited 1×
“Even though Benders and colleagues did not show improvement in outcomes with after-birth asphyxia [165], a recent follow-up study in human neonates with allopurinol used on term asphyxiated neonates showed benefits on mortality and severe disabilities at 4–8 years of age [166].”
ResultChen, W., Ma, Q., Suzuki, H., Hartman, R., Tang, J., & Zhang, J. H. (2011) · Stroke · doi:10.1161/strokeaha.110.599118 · Cited by 83 · cited 2×
“According to Chen and colleagues, OPN-induced neuroprotection was associated with cleaved caspase-3 inhibition and anti-apoptotic cell death, thereby improving long-term neurological function against neonatal HIE brain injury [137].”
BackgroundSelf-citationDonega, V., van Velthoven, C. T. J., Nijboer, C. H. A., Kavelaars, A., & Heijnen, C. J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.3 · Cited by 81 · cited 2×
“Therefore, understanding the molecular and cellular mechanism of neurogenesis and whether or not these mechanisms can be clinically applicable presents neurogenesis as a prime therapeutic target [50,51].”
BackgroundAn Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit
Du, W., Lehr, V. T., Lieh-Lai, M. W., Koo, W., Ward, R. M., Rieder, M. J., van den Anker, J. N., Reeves, J. H., Mathew, M., Lulic‐Botica, M., et al. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011433327 · Cited by 78 · cited 1×
“as in adverse drug reactions in the individualized neonatal treatment strategies [87].”
BackgroundGalinsky, R., Bennet, L., Groenendaal, F., Lear, C. A., Tan, S., van Bel, F., Juul, S. E., Robertson, N. J., Mallard, C. E., & Gunn, A. J. (2014) · Developmental Neuroscience · doi:10.1159/000362206 · Cited by 77 · cited 2×
“Differences in dose and timing of administration were present amidst evidence of beneficial effects [126].”
BackgroundResultNijboer, C. H. A., Bonestroo, H. J. C., Zijlstra, J., Kavelaars, A., & Heijnen, C. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.017 · Cited by 77 · cited 2×
“Reduced inflammation and inhibition of apoptotic neuronal loss [99]”
BackgroundMagnetic resonance imaging of brain angiogenesis after stroke
Seevinck, P. R., Deddens, L. H., & Dijkhuizen, R. M. (2010) · Angiogenesis · doi:10.1007/s10456-010-9174-0 · Cited by 73 · cited 1×
“importance that have been understudied [24,25].”
Comparison of Two Neonatal Ischemic Injury Models Using Magnetic Resonance Imaging
Ashwal, S., Tone, B., Tian, H. R., Chong, S., & Obenaus, A. (2007) · Pediatric Research · doi:10.1203/01.pdr.0000251612.16069.4b · Cited by 73 · cited 1×
“Obviously, the stroke model injury was defined on the ipsilateral middle cerebral artery territory, while more generalized and greater cortical ischemia occurred with the Rice-Vannucci method, even involving the contralateral side in some cases [65].”
MethodCurrent Management of the Infant Who Presents with Neonatal Encephalopathy
Wachtel, E. V., & Hendricks‐Muñoz, K. D. (2011) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2010.12.002 · Cited by 72 · cited 1×
“Although hypothermia does provide some protection, only 1 in 6 infants benefit from hypothermia [20].”
BackgroundWang, Y., Gu, Y.-T., Qin, G.-H., Zhong, L., & Meng, Y.-N. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9989-4 · Cited by 72 · cited 1×
“that show that stabilizing the BBB and reducing inflammatory markers after hypoxic ischemic events as well as HIE may be beneficial [36–40].”
BackgroundXia, G., Hong, X., Chen, X., Lan, F., Zhang, G., & Liao, L. (2010) · Journal of Perinatal Medicine · doi:10.1515/jpm.2010.021 · Cited by 70
Hypoxia Ischemia-Mediated Cell Death in Neonatal Rat Brain
Gill, M. B., & Perez-Polo, J. R. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9649-1 · Cited by 70 · cited 1×
“Although there have been major advances in modern technology and an increased understanding of fetal and neonatal pathologies, HIE is still a serious condition that is unresolved and causes significant mortality and long-term morbidity [4–7].”
BackgroundRescuing the neonatal brain from hypoxic injury with autologous cord blood
Liao, Y., Cotten, M., Tan, S., Kurtzberg, J., & Cairo, M. S. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.169 · Cited by 69 · cited 6×
“CB is rich in primitive stem cells, yet it contains a limited number of cell types, mostly mononuclear cells, and showed to be not as pluripotent as embryonic stem cells [133].”
BackgroundInfluentialWhat are the Best Animal Models for Testing Early Intervention in Cerebral Palsy?
Clowry, G. J., Basuodan, R., & Chan, F. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00258 · Cited by 69
Kaandorp, J. J., Benders, M. J. N. L., Schuit, E., Rademaker, C. M. A., Oudijk, M. A., PORATH, M. M., Oetomo, S. B., Wouters, M. G. A. J., van Elburg, R. M., Franssen, M. T. M., et al. (2014) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2014-306769 · Cited by 67 · cited 3×
“However, post hoc analysis revealed a potential benefit in treatment of females (NCT00189007) [114].”
BackgroundInfluentialA novel reproducible model of neonatal stroke in mice: Comparison with a hypoxia–ischemia model
Tsuji, M., Ohshima, M., Taguchi, A., Kasahara, Y., Ikeda, T., & Matsuyama, T. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.015 · Cited by 66 · cited 1×
“infarction area [68].”
Greenwood, K., Cox, P. M., Mehmet, H., Penrice, J., Amess, P., Cady, E. B., Wyatt, J. S., & Edwards, A. D. (2000) · Pediatric Research · doi:10.1203/00006450-200009000-00014 · Cited by 66 · cited 1×
“The studies in which the body temperature was controlled in large animal translational models suggested lack of effect after 2 or 3 days of recovery [182–184].”
BackgroundOsteopontin Enhances Endogenous Repair After Neonatal Hypoxic–Ischemic Brain Injury
van Velthoven, C. T. J., Heijnen, C. J., van Bel, F., & Kavelaars, A. (2011) · Stroke · doi:10.1161/strokeaha.110.608315 · Cited by 66
Chen, L.-X., Ma, S., Zhang, P., Fan, Z.-C., Xiong, M., Cheng, G., Yang, Y., Qiu, Z., Zhou, W., & Li, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115997 · Cited by 66
Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis
Tagin, M., Shah, P. S., & Lee, K. (2013) · Journal of Perinatology · doi:10.1038/jp.2013.65 · Cited by 65 · cited 1×
“magnesium therapy given shortly after birth to newborns with HIE reduces death or moderate-to-severe disability [127].”
BackgroundPark, M. H., Lee, S. M., Lee, J. W., Son, D. J., Moon, D. C., Yoon, D. Y., & Hong, J. T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.218 · Cited by 62 · cited 1×
“STAT5 acts on cell survival [161], while the ERK pathway has demonstrated not only to have anti-apoptotic and anti-inflammatory effects in vitro but also to be essential for neurogenesis and cell fate commitment [162,163].”
BackgroundJohnston, M. V., Ferriero, D. M., Vannucci, S. J., & Hagberg, H. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200121001 · Cited by 62
Nijboer, C. H. A., Heijnen, C. J., Groenendaal, F., van Bel, F., & Kavelaars, A. (2009) · Stroke · doi:10.1161/strokeaha.109.560250 · Cited by 61 · cited 2×
“(JNKs) JNKs play a role in regulation of apoptosis [97]; Reductions in early neuronal damage [98];”
BackgroundZhang, X., Zhang, Q., Li, W., Nie, D., Chen, W., Xu, C., Yi, X., Shi, J., Tian, M., Qin, J., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23304 · Cited by 61
Ang-(1–7) exerts protective role in blood–brain barrier damage by the balance of TIMP-1/MMP-9
Wu, J.-T., Zhao, D., Wu, S., & Wang, D. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.12.007 · Cited by 60 · cited 1×
“that show that stabilizing the BBB and reducing inflammatory markers after hypoxic ischemic events as well as HIE may be beneficial [36–40].”
BackgroundBrain Injury in the Infant: The Old, the New, and the Uncertain
Badr, L. K., & Purdy, I. B. (2006) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/00005237-200604000-00011 · Cited by 57 · cited 1×
“Although there have been major advances in modern technology and an increased understanding of fetal and neonatal pathologies, HIE is still a serious condition that is unresolved and causes significant mortality and long-term morbidity [4–7].”
BackgroundStem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy
Gonzales-Portillo, G. S., Reyes, S., Aguirre, D., Pabon, M. M., & Borlongan, C. V. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00147 · Cited by 56 · cited 1×
“Due to the lack of imaging diagnostic difficulties to detect HIE in premature newborns and insufficient data, present stem cell therapy trials are restricted to full term infants [189,190].”
Backgroundvan Velthoven, C. T. J., Braccioli, L., Willemen, H. L. D. M., Kavelaars, A., & Heijnen, C. J. (2013) · Molecular Therapy · doi:10.1038/mt.2013.260 · Cited by 56
Doycheva, D. M., Shih, G., Chen, H., Applegate, R. L., Zhang, J. H., & Tang, J. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0225-2 · Cited by 55 · cited 2×
“G-CSF [3], and glial-cell derived neurotrophic factor have shown promising results [191].”
BackgroundSelf-citationOutcomes of Hypoxic-Ischemic Encephalopathy in Neonates Treated with Hypothermia
Shankaran, S. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2013.10.008 · Cited by 54 · cited 1×
“There have been several completed clinical trials concerning Epo after HIE injury [150,157–159].”
BackgroundNoor, J. I., Ikeda, T., 三島, 健., Aoo, N., Ohta, S., Egashira, N., Iwasaki, K., Fujiwara, M., & Ikenoue, T. (2005) · Stroke · doi:10.1161/01.str.0000185653.49740.c6 · Cited by 51 · cited 1×
“Furthermore another study showed that intraperitoneal administration of edaravone after HIE for consecutive days improved memory and learning ability when given in the acute phase of HIE [147].”
Yang, D., Nemkul, N., Shereen, A. D., Jone, A., Dunn, R. S., Lawrence, D. A., Lindquist, D., & Kuan, C.-Y. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1117-09.2009 · Cited by 51 · cited 1×
“matrix and the BBB [42].”
Neonatal Seizures: Gaps Between the Laboratory and the Clinic
LOMBROSO, C. T. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01070.x · Cited by 50 · cited 1×
“Subtle, clonic, tonic, myoclonic that are focal, multifocal, or generalized are the most common types of seizures that present [13–15].”
BackgroundProphylactic Phenobarbital and Whole-Body Cooling for Neonatal Hypoxic-Ischemic Encephalopathy
Meyn, D. F., Ness, J., Ambalavanan, N., & Carlo, W. A. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.005 · Cited by 46 · cited 3×
“and colleagues [100] analyzed the effects of prophylactic administration of phenobarbital to infants with HIE.”
BackgroundMethodInfluentialFathali, N., Lekic, T., Zhang, J. H., & Tang, J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1913-6 · Cited by 46 · cited 1×
“These adverse events in the developing brain often lead to long lasting detrimental neurological defects later on in life such as mental retardation, epilepsy, cerebral palsy, learning disabilities, and other neurophysiological handicaps [8].”
BackgroundSelf-citationDedifferentiation-Reprogrammed Mesenchymal Stem Cells with Improved Therapeutic Potential
Liu, Y., Jiang, X., Zhang, X., Chen, R., Sun, T., Fok, K. L., Dong, J., Tsang, L. L., Yi, S., Ruan, Y. C., et al. (2011) · Stem Cells · doi:10.1002/stem.764 · Cited by 46
Greggio, S., de Paula, S., Azevedo, P. N., Venturin, G. T., & DaCosta, J. C. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.10.017 · Cited by 46
One, Two, Three Steps Toward Cell Therapy for Stroke
Diamandis, T., & Borlongan, C. V. (2014) · Stroke · doi:10.1161/strokeaha.114.007105 · Cited by 45 · cited 1×
“Stem cell therapy represents a modern cornerstone of promising neuroprotective and neuroregenerative treatment options that can benefit from ongoing trials, especially in adult stroke [128].”
BackgroundWayock, C. P., Meserole, R. L., Saria, S., Jennings, J. M., Huisman, T. A. G. M., Northington, F. J., & Graham, E. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.03.033 · Cited by 43 · cited 1×
“Care for newborn infants at risk for hypoxia ischemia is a priority in health care and understanding the pathophysiology of hypoxic ischemic brain injury is quite essential to the design of effective interventions [9].”
BackgroundZhao, T., Zhang, X., Zhao, Y., Zhang, L., Bai, X., Zhang, J., Zhao, X., Chen, L., Wang, L., & Cui, L. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1356-5 · Cited by 43
Self-citationÖzyener, F., Çetınkaya, M., ALKAN, T., Gören, B., Kafa, İ. M., Kurt, M. A., & Köksal, N. (2012) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2012-120217 · Cited by 42 · cited 1×
“TPM in concert with melatonin decreases infarcted volume and apoptosis in neonatal HIE rat model [124].”
BackgroundBaby STEPS: A Giant Leap for Cell Therapy in Neonatal Brain Injury
Borlongan, C. V., & Weiss, M. D. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e31821d0d00 · Cited by 42 · cited 1×
“Due to the lack of imaging diagnostic difficulties to detect HIE in premature newborns and insufficient data, present stem cell therapy trials are restricted to full term infants [189,190].”
BackgroundReplacing animal experiments: choices, chances and challenges
Langley, G., Evans, T. J., Holgate, S. T., & Jones, A. K. P. (2007) · BioEssays · doi:10.1002/bies.20628 · Cited by 41 · cited 1×
“Although much progress in experimental development and technology has been made in the past few decades, the issue of discovering disease models, that can mimic human pathophysiology sufficiently, remains an ongoing challenge [73,77,78].”
BackgroundNoor, J. I., Ueda, Y., Ikeda, T., & Ikenoue, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.024 · Cited by 35 · cited 2×
“Edaravone is believed to interact with peroxyl and hydroxyl radicals creating a radical intermediate that forms stable oxidation products [105,106].”
BackgroundMethodTeo, L., & Bourne, J. A. (2014) · Brain Pathology · doi:10.1111/bpa.12129 · Cited by 35 · cited 1×
“post-ischemic observations in newborns [71].”
Turner, M. A. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.08.014 · Cited by 34 · cited 1×
“Due to the small size and huge variability of pediatric patients, neonatal pharmacotherapies are limited to mostly off label usage of compounds developed for adults to extrapolate dosages [84–86].”
BackgroundInterferon-β Fails to Protect in a Model of Transient Focal Stroke
Maier, C. M., Yu, F., Nishi, T., Lathrop, S. J., & Chan, P. H. (2006) · Stroke · doi:10.1161/01.str.0000208214.46093.d5 · Cited by 33 · cited 1×
“It appears that IFNβ is unable to cross BBB; thus, methods to circumvent the BBB are needed in order for IFNβ to be effective [140].”
BackgroundShokry, M., Elsedfy, G. O., Bassiouny, M., ANMIN, M., & Yousef, H. A. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016341003739542 · Cited by 31 · cited 1×
“Evidence leads researchers to believe that it also reduces secondary inflammation and associated injury [179], acts on cell membrane stabilization and inhibition of free radical production [180], and improves cardiovascular stability [181].”
BackgroundTakizawa, Y., Miyazawa, T., Nonoyama, S., Goto, Y., & Itoh, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181a16a9f · Cited by 31 · cited 2×
“Edaravone is believed to interact with peroxyl and hydroxyl radicals creating a radical intermediate that forms stable oxidation products [105,106].”
BackgroundMethodNi, X., Yang, Z.-J., Carter, E. L., Martin, L. J., & Koehler, R. C. (2011) · Developmental Neuroscience · doi:10.1159/000327243 · Cited by 28 · cited 2×
“Scavenger that inhibits both lipid and DNA peroxidation [107]”
BackgroundWang, X., Zhao, Y., & Wang, X. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.019 · Cited by 28
Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach
van den Anker, J., & Allegaert, K. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.65 · Cited by 25
Kaandorp, J. J., van den Broek, M. P. H., Benders, M. J. N. L., Oudijk, M. A., PORATH, M. M., Oetomo, S. B., Wouters, M. G. A. J., van Elburg, R. M., Franssen, M. T. M., Bos, A., et al. (2013) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2013-304876 · Cited by 22 · cited 1×
“effectiveness [144].”
Shaikh, H., Lechpammer, M., Jensen, F. E., Warfield, S. K., Hansen, A. H., Kosaras, B., Shevell, M. I., & Wintermark, P. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0387-9 · Cited by 21
The Neonatal Brain Is Not Protected by Osteopontin Peptide Treatment after Hypoxia-Ischemia
Bonestroo, H. J. C., Nijboer, C. H. A., van Velthoven, C. T. J., van Bel, F., & Heijnen, C. J. (2015) · Developmental Neuroscience · doi:10.1159/000369093 · Cited by 21 · cited 1×
“), and intracerebral administration of a small TAT-OPN peptide was neither neuroprotective by measuring the anatomical reduction of the HIE induced brain injury, nor beneficial in reducing sensorimotor behavioral deficits [138].”
BackgroundGuidi, S., Bianchi, P., Alstrup, A. K. O., Henningsen, K., Smith, D. F., & Bartesaghi, R. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.03.028 · Cited by 20 · cited 1×
“Although there is evidence that suggests that neurogenesis increases after injuries such as HIE, the endogenous repair mechanisms do not resolve the brain damage that occurs [48–50].”
BackgroundA clinically relevant model of perinatal global ischemic brain damage in rats
Yang, T., Zhuang, L., Terrando, N., Xin-min, W., Jonhson, M. R., Maze, M., & Ma, D. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.081 · Cited by 18 · cited 1×
“Other new promising neonatal hypoxic-ischemic models have been introduced recently, like a perinatal global ischemic brain injury model in rats providing intrapartum hypoxia in rats [66].”
BackgroundThe Evolving Landscape of Neuroinflammation After Neonatal Hypoxia-Ischemia
Fathali, N., Khatibi, N. H., Ostrowski, R. P., & Zhang, J. H. (2011) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-0693-8_15 · Cited by 17 · cited 2×
“Presently, there are no well-established effective therapies for neonatal HIE [19].”
BackgroundSelf-citationThe effect of ASK1 on vascular permeability and edema formation in cerebral ischemia
Song, J., Cheon, S. Y., Lee, W. T., Park, K. A., & Lee, J. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.024 · Cited by 16 · cited 1×
“that show that stabilizing the BBB and reducing inflammatory markers after hypoxic ischemic events as well as HIE may be beneficial [36–40].”
BackgroundHuang, Y., Lai, H., Xu, H., Wu, W., Lai, X., Ho, G., Ma, L., & Chen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082502 · Cited by 14 · cited 1×
“placenta blood supply to the fetuses to mimic brain damage in early preterm newborns [67].”
BackgroundAngiogenesis Dysregulation in Term Asphyxiated Newborns Treated with Hypothermia
Shaikh, H., Boudes, E., Khoja, Z., Shevell, M. I., & Wintermark, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128028 · Cited by 13 · cited 1×
“While asphyxiated newborns that did not develop brain injury showed increases in fatty acid binding protein 4, glucose-6-phosphate isomerase, expression of neuropilin-1 (a vascular endothelial growth factor receptor-2 co-receptor), and receptor tyrosine-protein kinase erbB-3, which are proteins associated with endothe…”
BackgroundThe importance of temperature on the neurovascular unit
Laptook, A. R. (2014) · Early Human Development · doi:10.1016/j.earlhumdev.2014.06.008 · Cited by 11 · cited 4×
“Numerous in vitro and in vivo studies have revealed that VEGF and matrix metalloproteinases (MMP) are involved in the initial opening of the BBB within hours of an hypoxic-ischemic event [32].”
BackgroundInfluential
Cited by
Tarocco, A., Caroccia, N., Morciano, G., Wieckowski, M. R., Ancora, G., Garani, G., & Pinton, P. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1556-7 · Cited by 299
Wang, B., Yu, P., Lin, W., & Zhai, Z. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/5543212 · Cited by 5
Metadata
- Authors
- Dixon, B., Reis, C., Ho, W., Tang, J., & Zhang, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-09-15
- Volume
- 16
- Issue
- 9
- Pages
- 22368-22401
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2147080637
- Cited by
- 182
- References
- 197
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.